5 Lung Cancer Clinical Trials in Lone Tree, CO (2026)

Q: How do I join a clinical trial in Lone Tree?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Lone Tree research site will contact you.

Recruiting Lung Cancer Studies in Lone Tree

NCT06119581Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

The purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated ad...

Lone Tree, COPHASE31,264 participantsEli Lilly and Company

View Study Details

NCT06772623Recruiting

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Non small cell lung carcinoma (NSCLC) is the most frequently occurring histologic subtype of lung cancer and is the leading cause of cancer-related deaths worldwide. The purpose of this study is to as...

Lone Tree, COPHASE1252 participantsAbbVie

View Study Details

NCT04486833Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

The purpose of this randomized study is to determine the safety and efficacy of quaratusugene ozeplasmid (Reqorsa) added to osimertinib in NSCLC patients with activating EGFR mutations who have progre...

Lone Tree, COPHASE1158 participantsGenprex, Inc.

View Study Details

NCT06095505Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer (SCLC) following progression on or after treatment with one platinum-...

Lone Tree, COPHASE2120 participantsPuma Biotechnology, Inc.

View Study Details

NCT05703971Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

This clinical trial will evaluate the combination of quaratusugene ozeplasmid with atezolizumab as maintenance therapy for patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC). The study is...

Lone Tree, COPHASE162 participantsGenprex, Inc.

View Study Details

About Lung Cancer Clinical Trials in Lone Tree

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 5 lung cancer clinical trials recruiting participants in Lone Tree, CO. These studies are seeking a combined 1,856 participants. Research is being sponsored by Eli Lilly and Company, AbbVie, Genprex, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Lone Tree — FAQ

Are there lung cancer clinical trials in Lone Tree?

Yes, there are 5 lung cancer clinical trials currently recruiting in Lone Tree, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lone Tree?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lone Tree research site will contact you about next steps.

Are clinical trials in Lone Tree free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lone Tree studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 5 active trials in Lone Tree are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 22, 2026 from ClinicalTrials.gov